CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRn
用户wxb8loTerxGI
1个月前
120
10
已完结
1. 系统已在2026-05-21 15:20:59对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
S Wymann, RAV Morales, WH Toh…
International Journal of …, 2026
mdpi.com
… IgG-based complement inhibitor would be expected to be accelerated by the co-administered FcRn … Having demonstrated CSL305 acting as a complement inhibitor and FcRn …

